The utility of PSA doubling time to monitor prostate cancer recurrence

Mayo Clin Proc. 2001 Jun;76(6):571-2. doi: 10.4065/76.6.571.
No abstract available

Publication types

  • Comment
  • Editorial
  • Review

MeSH terms

  • Biomarkers, Tumor / blood*
  • Disease Progression
  • Humans
  • Male
  • Neoplasm Recurrence, Local / blood*
  • Neoplasm Recurrence, Local / diagnosis*
  • Neoplasm Recurrence, Local / therapy
  • Predictive Value of Tests
  • Prognosis
  • Prostate-Specific Antigen / blood*
  • Prostatic Neoplasms / blood*
  • Prostatic Neoplasms / diagnosis*
  • Prostatic Neoplasms / therapy
  • Reproducibility of Results
  • Risk Factors
  • Time Factors
  • Treatment Outcome

Substances

  • Biomarkers, Tumor
  • Prostate-Specific Antigen